Holen Sie sich die Stockscreener-App
114.70
0.08%
-0.09
Schlusskurs vom Vortag:
$114.79
Offen:
$114.36
24-Stunden-Volumen:
279.82K
Relative Volume:
0.67
Marktkapitalisierung:
$1.06B
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-1.41%
1M Leistung:
+3.01%
6M Leistung:
+15.36%
1J Leistung:
+23.93%
1-Tages-Spanne:
$114.20
$115.31
1-Wochen-Bereich:
$114.20
$118.03
52-Wochen-Spanne:
$90.74
$118.03
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PPH vs VOO, IVV, SPY, VTI, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
114.70 | 1.06B | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
707.80 | 1.04T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.46 | 885.61B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.99 | 817.10B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
378.02 | 696.23B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
721.45 | 486.91B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? - The Motley Fool
VanEck Pharmaceutical ETF (PPH) Stock Price | Quotes & News - Moomoo
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Zacks Investment Research
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now? - Zacks Investment Research
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Globe and Mail
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Motley Fool
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Globe and Mail
Execution of Pharma Tariffs Brings These ETFs Into Focus - TradingView
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Zacks Investment Research
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance Singapore
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo! Finance Canada
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Globe and Mail
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.3600 - TradingView
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Motley Fool
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Globe and Mail
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Waverly Advisors LLC Has $4.23 Million Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Comparing Healthcare ETFs: Broad vs. Focused Exposure - Intellectia AI
Parker Hannifin Corp. stock outperforms competitors on strong trading day - MarketWatch
Parker-Hannifin (NYSE: PH) exec gives away 1,056 shares - Stock Titan
Q2 Earnings Highlights: Parker-Hannifin (NYSE:PH) Vs The Rest Of The Gas and Liquid Handling Stocks - Yahoo Finance
PH6508118 Bond Yield and Price — FINRA:PH6508118 - TradingView
Insider Transaction: Laura Thompson Sells $153K Worth Of Parker Hannifin Shares - Benzinga
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Motley Fool
Why is Parker-Hannifin (NYSE:PH) stock in focus today? - Kalkine Media
Tidal Investments LLC Has $19.99 Million Holdings in Parker-Hannifin Corporation $PH - MarketBeat
NewEdge Advisors LLC Boosts Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Globe and Mail
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - Yahoo Finance
Director Laura Thompson Sells 160 Shares of Parker Hannifin Corp (PH) - GuruFocus
Parker-Hannifin Director Laura K. Thompson Sells 160 Shares at $958.95 Each - Kalkine Media
Parker Hannifin Corp. stock outperforms competitors despite losses on the day - MarketWatch
Parker-Hannifin prices $4.425B combined U.S. and Euro note offerings to refinance term loan - TradingView
Parker-Hannifin (NYSE: PH) Launches Euro Senior Notes Maturing in 2030, 2032, and 2036 to Finance FGC Acquisition Debt - Kalkine Media
Sequoia Financial Advisors LLC Increases Stake in Parker-Hannifin Corporation $PH - MarketBeat
National Pension Service Acquires 10,590 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Parker-Hannifin Corporation $PH Shares Sold by C WorldWide Group Holding A S - MarketBeat
Allworth Financial LP Acquires 1,598 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Baird Financial Group Inc. Increases Stock Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Parker-Hannifin Corporation $PH Shares Bought by Carmignac Gestion - MarketBeat
Parker-Hannifin Boosts Credit Facility, Commercial Paper Program to $5.0 Billion - Minichart
Form 424B2 Parker-Hannifin Corp - StreetInsider
Parker-Hannifin increases revolving credit and commercial paper to $5.0B, plans $2.0B delayed draw loan - TradingView
Anchor Capital Advisors LLC Sells 1,488 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Director sells shares at $958.95 each at Parker-Hannifin (NYSE: PH) - Stock Titan
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):